{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:35:03Z","timestamp":1761896103182},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T00:00:00Z","timestamp":1434240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11255-015-1029-6","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T06:08:02Z","timestamp":1434175682000},"page":"1251-1257","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?"],"prefix":"10.1007","volume":"47","author":[{"given":"Bu Hyeon","family":"Yun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eu Chang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Song","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoseok","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Ouck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Il","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taek won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Deuk","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangsung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,14]]},"reference":[{"key":"1029_CR1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0090-4295(00)00790-1","volume":"56","author":"RO Roberts","year":"2000","unstructured":"Roberts RO, Bergstralh EJ, Lieber MM, Jacobsen SJ (2000) Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997. Urology 56:817\u2013822","journal-title":"Urology"},{"key":"1029_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0033-8389(05)70151-2","volume":"38","author":"PJ Littrup","year":"2000","unstructured":"Littrup PJ, Bailey SE (2000) Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management. Radiol Clin N Am 38:87\u2013113","journal-title":"Radiol Clin N Am"},{"key":"1029_CR3","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/S0022-5347(05)64999-3","volume":"167","author":"KA Roehl","year":"2002","unstructured":"Roehl KA, Antenor JA, Catalona WJ (2002) Serial biopsy results in prostate cancer screening study. J Urol 167:2435\u20132439","journal-title":"J Urol"},{"key":"1029_CR4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","volume":"183","author":"RK Nam","year":"2010","unstructured":"Nam RK, Saskin R, Lee Y et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963\u2013968","journal-title":"J Urol"},{"key":"1029_CR5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-5347(17)40079-6","volume":"143","author":"AW Partin","year":"1990","unstructured":"Partin AW, Carter HB, Chan DW et al (1990) Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 143:747\u2013752","journal-title":"J Urol"},{"key":"1029_CR6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-5347(01)67064-2","volume":"154","author":"RB Nadler","year":"1995","unstructured":"Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL (1995) Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 154:407\u2013413","journal-title":"J Urol"},{"key":"1029_CR7","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/01.ju.0000158161.15277.78","volume":"173","author":"RJ Cohen","year":"2005","unstructured":"Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL (2005) Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J Urol 173:1969\u20131974","journal-title":"J Urol"},{"key":"1029_CR8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1464-410x.2001.02193.x","volume":"87","author":"JC Nickel","year":"2001","unstructured":"Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID (2001) Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 87:797\u2013805","journal-title":"BJU Int"},{"key":"1029_CR9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","volume":"157","author":"J Irani","year":"1997","unstructured":"Irani J, Levillain P, Goujon JM, Bon D, Dor\u00e9 B, Aubert J (1997) Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 157:1301\u20131303","journal-title":"J Urol"},{"key":"1029_CR10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5347(01)64518-X","volume":"158","author":"NE Fleshner","year":"1997","unstructured":"Fleshner NE, O\u2019Sullivan M, Fair WR (1997) Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 158:505\u2013508","journal-title":"J Urol"},{"key":"1029_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1442-2042.1999.00611.x","volume":"6","author":"M Noguchi","year":"1999","unstructured":"Noguchi M, Yahara J, Koga H, Nakashima O, Noda S (1999) Necessity of repeat biopsies in men for suspected prostate cancer. Int J Urol 6:7\u201312","journal-title":"Int J Urol"},{"key":"1029_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1464-410x.1999.00864.x","volume":"83","author":"GC Durkan","year":"1999","unstructured":"Durkan GC, Greene DR (1999) Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy? BJU Int 83:34\u201338","journal-title":"BJU Int"},{"key":"1029_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.juro.2009.04.016","volume":"182","author":"JL Merrimen","year":"2009","unstructured":"Merrimen JL, Jones G, Walker D, Leung CS, Kapusta LR, Srigley JR (2009) Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol 182:485\u2013490","journal-title":"J Urol"},{"key":"1029_CR14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4111\/kju.2012.53.7.467","volume":"53","author":"JG Lee","year":"2012","unstructured":"Lee JG, Bae SH, Choi SH, Kwon TG, Kim TH (2012) Role of prostate-specific antigen change ratio at initial biopsy as a novel decision-making marker for repeat prostate biopsy. Korean J Urol 53:467\u2013471","journal-title":"Korean J Urol"},{"key":"1029_CR15","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/jama.279.19.1542","volume":"279","author":"WJ Catalona","year":"1998","unstructured":"Catalona WJ, Partin AW, Slawin KM et al (1998) Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279:1542\u20131547","journal-title":"JAMA"},{"key":"1029_CR16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0090-4295(96)00615-2","volume":"48","author":"TO Morgan","year":"1996","unstructured":"Morgan TO, McLeod DG, Leifer ES, Murphy GP, Moul JW (1996) Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen. Urology 48:76\u201380","journal-title":"Urology"},{"key":"1029_CR17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrurol.2014.143","volume":"11","author":"L Vignozzi","year":"2014","unstructured":"Vignozzi L, Maggi M (2014) Prostate cancer: intriguing data on inflammation and prostate cancer. Nat Rev Urol 11:369\u2013370","journal-title":"Nat Rev Urol"},{"key":"1029_CR18","doi-asserted-by":"crossref","first-page":"329456","DOI":"10.1155\/2014\/329456","volume":"2014","author":"G Corona","year":"2014","unstructured":"Corona G, Vignozzi L, Rastrelli G, Lotti F, Cipriani S, Maggi M (2014) Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int J Endocrinol 2014:329456","journal-title":"Int J Endocrinol"},{"key":"1029_CR19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ajcp\/92.6.760","volume":"92","author":"MK Brawer","year":"1989","unstructured":"Brawer MK, Rennels MA, Nagle RB, Schifman R, Gaines JA (1989) Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy. Am J Clin Pathol 92:760\u2013764","journal-title":"Am J Clin Pathol"},{"key":"1029_CR20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000020161","volume":"37","author":"PH Schatteman","year":"2000","unstructured":"Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E (2000) Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 37:404\u2013412","journal-title":"Eur Urol"},{"key":"1029_CR21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.urology.2007.06.1102","volume":"70","author":"E Kandirali","year":"2007","unstructured":"Kandirali E, Boran C, Serin E, Semercioz A, Metin A (2007) Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients. Urology 70:743\u2013747","journal-title":"Urology"},{"key":"1029_CR22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4111\/kju.2009.50.2.154","volume":"50","author":"HW Kim","year":"2009","unstructured":"Kim HW, Kim SH, Kim SW, Jung KI, Min KO, Cho SY (2009) Effects of subclinical prostatitis on benign prostatic hyperplasia. Korean J Urol 50:154\u2013158","journal-title":"Korean J Urol"},{"key":"1029_CR23","first-page":"74","volume":"7","author":"CH Park","year":"2009","unstructured":"Park CH, Kim SJ, Park CM, Kim HK, Park JY (2009) The influence of prostate chronic inflammation on parameters related to prostate cancer in asymptomatic patients. Korean J Urol Oncol 7:74\u201381","journal-title":"Korean J Urol Oncol"},{"key":"1029_CR24","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.urology.2008.07.028","volume":"72","author":"T Terakawa","year":"2008","unstructured":"Terakawa T, Miyake H, Kanomata N, Kumano M, Takenaka A, Fujisawao M (2008) Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10\u201350\u00a0ng\/mL. Urology 72:1194\u20131197","journal-title":"Urology"},{"key":"1029_CR25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000328043","volume":"87","author":"P Pepe","year":"2011","unstructured":"Pepe P, Aragona F (2011) Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy? Urol Int 87:171\u2013174","journal-title":"Urol Int"},{"key":"1029_CR26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126","volume":"23","author":"B Gurel","year":"2014","unstructured":"Gurel B, Lucia MS, Thompson IM Jr et al (2014) Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomark Prev 23:847\u2013856","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1029_CR27","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.juro.2010.12.058","volume":"185","author":"K Fujita","year":"2011","unstructured":"Fujita K, Hosomi M, Tanigawa G, Okumi M, Fushimi H, Yamaguchi S (2011) Prostatic inflammation detected in initial biopsy specimens and urinary pyuria are predictors of negative repeat prostate biopsy. J Urol 185:1722\u20131727","journal-title":"J Urol"},{"key":"1029_CR28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cncr.28349","volume":"120","author":"DM Moreira","year":"2014","unstructured":"Moreira DM, Nickel JC, Gerber L et al (2014) Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study. Cancer 120:190\u2013196","journal-title":"Cancer"},{"key":"1029_CR29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bju.12153","volume":"112","author":"TH Yli-Hemminki","year":"2013","unstructured":"Yli-Hemminki TH, Laurila M, Auvinen A et al (2013) Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial. BJU Int 112:735\u2013741","journal-title":"BJU Int"},{"key":"1029_CR30","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.juro.2008.01.034","volume":"179","author":"NB Delongchamps","year":"2008","unstructured":"Delongchamps NB, de la Roza G, Chandan V et al (2008) Evaluation of prostatitis in autopsied prostates-is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol 179:1736\u20131740","journal-title":"J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1029-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-015-1029-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1029-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T21:54:44Z","timestamp":1566856484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-015-1029-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,14]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1007\/s11255-015-1029-6","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,14]]}}}